Business · 1 sources covering this

Emcure Pharma up over 3% as board approves merger of two subsidiaries

Emcure Pharmaceuticals will merge its wholly owned subsidiaries, Zuventus Healthcare and Emcutix Biopharmaceuticals, with itself under the proposed scheme.

Share:WhatsApp X Reddit Facebook LinkedIn

Coverage spectrum

0 L · 1 C · 0 R

How 1 sources are covering this

Business StandardCenter·1h ago
Emcure Pharma up over 3% as board approves merger of two subsidiaries
Emcure Pharmaceuticals will merge its wholly owned subsidiaries, Zuventus Healthcare and Emcutix Biopharmaceuticals, with itself under the proposed scheme.
Read at Business Standard →

Embed this bias spectrum on your site

Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.

<iframe
  src="https://hindustansphere.com/embed/cluster/083a8eeaa52f9065e9fb9a8d6ba6e3ad2fff07db"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="Emcure Pharma up over 3% as board approves merger of two subsidiaries"></iframe>

Emcure Pharma up over 3% as board approves merger of two subsidiaries

How 1 sources are covering this

Emcure Pharma up over 3% as board approves merger of two subsidiaries

More from Business

Reliance Industries hits 18-month low; stock down 28% from January low

63 Moons Tech shares surge 12% after subsidiary raises FY27 guidance

Jantar Mantar de-notified as protest venue, Delhi Police circular says | All you need to know

No adjudication on new Form 6 while hearing Bihar SIR matter, says SC

Reader

Trust & legal

Across the network